Natera
Natera is a genetic testing and diagnostics company that develops and commercializes cell-free DNA assays for reproductive health, oncology, and organ health. It serves healthcare providers, hospitals, and biopharmaceutical companies with tests for non-invasive prenatal screening, hereditary cancer risk, minimal residual disease, and transplant rejection monitoring, generating revenue through test processing fees and related services. Natera also partners with life sciences organizations for clinical trials and companion diagnostics programs.
- Clinical Trial & Research Software
- Electronic Health Records
- Revenue
- $1.1B
- Employees
- 3,500
- Founded
- 2004
- Headquarters
- Austin, United States of America
What 6 Arbolus experts think of Natera
6 customers have reviewed Natera so far. The full customer report is in progress and publishes once enough customers have been interviewed in depth.
Who reviewed Natera
- C-Suite 83% (5)
- Director 17% (1)
Employer names and spend open once the report publishes.
Tell us when the Natera report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
33 Net Promoter Score, from 6 scored reviews- Promoters 3
- Passives 2
- Detractors 1
Cumulative NPS by month
+0 over 3 months- Jan 8
- Jul 8
- Aug 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 33 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 25%Plan to renew, by seniority
- 0% 3 answers
- 100% 1 answer
- 9/10 Average score from customers who will renew
- 7.3/10 Average score from undecided customers
For people who use Natera
Do you use Natera at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 6 customers of Natera have already contributed
Takes a few minutes. Your identity stays anonymous.